NCT06851702View on ClinicalTrials.gov

Observational Study for the Evaluation of Immune-mediated Endocrinological Adverse Events in Patients With Hematological Malignancies and Subjected to Treatment With Immune-checkpoint Inhibitors

RecruitingOBSERVATIONAL

Enrollment

100

Participants

Timeline

Start Date

June 30, 2025

Primary Completion Date

December 31, 2025

Study Completion Date

December 31, 2025

Conditions

Hematological Malignancies

Trial Locations (1)

40138

RECRUITING

IRCCS Azienda Ospedaliero - Universitaria di Bologna, Bologna

All Listed Sponsors

lead

IRCCS Azienda Ospedaliero-Universitaria di Bologna

OTHER

NCT06851702 - Observational Study for the Evaluation of Immune-mediated Endocrinological Adverse Events in Patients With Hematological Malignancies and Subjected to Treatment With Immune-checkpoint Inhibitors | Biotech Hunter | Biotech Hunter